Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Serum predictive cytokine validation in Rheumatoid Arthritis to withdraw Orencia by using ultrasound analysis

Trial Profile

Serum predictive cytokine validation in Rheumatoid Arthritis to withdraw Orencia by using ultrasound analysis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2018

At a glance

  • Drugs Abatacept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms SOROBAN
  • Most Recent Events

    • 23 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top